Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Nurix Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- +10 vs. Q2 2021
- Shares held
- 39.5M
- +627.9K (+1.6%) vs. Q2 2021
- Total value
- $1.18B
- +$153.0M (+14.8%) vs. Q2 2021
- New holders
- 25
- 33 more added
- Sold out
- 15
- 32 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $2.84B |
| Q1 2026 | 196 | $1.81B |
| Q4 2025 | 182 | $2.15B |
| Q3 2025 | 173 | $783.3M |
| Q2 2025 | 164 | $1.01B |
| Q1 2025 | 170 | $1.01B |
| Q4 2024 | 175 | $1.53B |
| Q3 2024 | 172 | $1.53B |
| Q2 2024 | 174 | $1.36B |
| Q1 2024 | 139 | $721.3M |
| Q4 2023 | 131 | $475.6M |
| Q3 2023 | 129 | $352.5M |
| Q2 2023 | 126 | $435.7M |
| Q1 2023 | 124 | $376.6M |
| Q4 2022 | 119 | $468.6M |
| Q3 2022 | 118 | $561.0M |
| Q2 2022 | 106 | $568.4M |
| Q1 2022 | 117 | $565.6M |
| Q4 2021 | 125 | $1.17B |
| Q3 2021 | 113 | $1.18B |
| Q2 2021 | 104 | $1.05B |
| Q1 2021 | 101 | $1.29B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wasatch Advisors Inc | 1,171,657 | $35.1M | 0.14% | −22,958−1.9% | Reduced |
| Eventide Asset Management, LLC | 1,200,000 | $36.0M | 0.48% | 00.0% | Unchanged |
| Foresite Capital Management IV, LLC | 1,205,798 | $36.1M | 5.32% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,224,892 | $36.7M | 1.28% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,226,058 | $36.7M | 0.01% | −168,833−12.1% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $38.5M | 2.39% | 00.0% | Unchanged |
| State Street Corp | 1,633,131 | $48.9M | 0.00% | −226,337−12.2% | Reduced |
| Vanguard Group Inc | 1,977,951 | $59.3M | 0.00% | +511,814+34.9% | Added |
| TRV GP III, LLC | 2,422,549 | $72.6M | 13.78% | −1,000,000−29.2% | Reduced |
| Baker Bros. Advisors LP | 2,454,082 | $73.5M | 0.32% | 00.0% | Unchanged |
| BlackRock Inc. | 2,483,573 | $74.4M | 0.00% | +396,957+19.0% | Added |
| Redmile Group, LLC | 3,093,077 | $92.7M | 1.62% | −97,000−3.0% | Reduced |
| Price T Rowe Associates Inc | 4,718,877 | $141.4M | 0.01% | +667,399+16.5% | Added |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −244,157−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −224,686−100.0% | Sold out |
| Euclidean Capital LLC | 0 | $0 | 0.00% | −154,426−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −106,320−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −78,527−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −43,826−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −29,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −24,012−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −12,663−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,558−100.0% | Sold out |
| Hershey Trust Co | 0 | $0 | 0.00% | −8,807−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −7,574−100.0% | Sold out |
| Chescapmanager LLC | 0 | $0 | 0.00% | −7,442−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −5,749−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −116−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |